Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
HYDROXYUREA CAPSULES USP
Medication labelWhy this: Advisory · dailymed-prescription
Significant tumor response to hydroxyurea capsules USP has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary. Hydroxyurea, USP used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip.
- generic_name
- hydroxyurea
- product_names
- Hydroxyurea
- ndc
- 54868-4773, 0555-0882, 54868-4773-0, 54868-4773-1, 54868-4773-2, 54868-4773-3, 54868-4773-4
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en